Cointime

Octant Bio

company

About

Octant Bio is a developer of synthetic technology used to improve health and treat disease.

  • 11 - 50

Highlights

Total Funding Amount
$110M
Funding Rounds
2
Investors
1

Details

Last Funding Type
Series B
Last Funding Money Raised
$80M
Industries
Biotechnology,Life Science
Founded date
Jan 1, 2017
Number Of Employee
11 - 50
Operating Status
Active

Octant Bio is a developer of synthetic technology used to improve health and treat disease. Its technology uses synthetic biology, genome engineering, next-generation sequencing, and computational tools to simultaneously measure the activity of thousands of receptor pathways in human cells that enable scientists to apply machine learning methods to engineer small molecules that interact with multiple receptors and unlock a new potential to treat complex diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$110M
Octant Bio has raised a total of $110M in funding over 2 rounds. Their latest funding was raised on Apr 28, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 28, 2022 Series B $80M 1 — — Detail
May 21, 2020 Series A $30M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Octant Bio is funded by 1 investors. Allen & Company are the most recent investors.
Investor Name Lead Investor Funding Round
Allen & Company — Series B
Cointime
เนื้อหา
บริษัท